(Q36378606)

13 August 2017

1 reference

title

Challenges in the concurrent management of malaria and HIV in pregnancy in sub-Saharan Africa (English)

1 reference

pregnancy-associated malaria

13 August 2017

0 references

0 references

0 references

1 reference

Paula E Brentlinger

1

0 references

author name string

Christopher B Behrens

series ordinal

2

1 reference

13 August 2017

Mark A Micek

series ordinal

3

1 reference

13 August 2017

publication date

1 February 2006

1 reference

Lancet Infectious Diseases

13 August 2017

published in

1 reference

13 August 2017

volume

6

1 reference

13 August 2017

issue

2

1 reference

13 August 2017

page(s)

100-111

1 reference

The burden of malaria in pregnancy in malaria-endemic areas.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Post-neonatal infant mortality in Malawi: the importance of maternal health

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Determinants of low birth weight among HIV-infected pregnant women in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

The effect of dual infection with HIV and malaria on pregnancy outcome in western Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Coma in Mozambican gravidas: causes and perinatal outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Unstable malaria transmission and maternal mortality--experiences from Rwanda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

HIV increases the risk of malaria in women of all gravidities in Kisumu, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Effectiveness of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in western Kenya: a hospital-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-99.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

The efficacy of antimalarial monotherapies, sulphadoxine–pyrimethamine and amodiaquine in East Africa: implications for sub‐regional policy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Prevention of anaemia in pregnancy using insecticide-treated bednets and sulfadoxine-pyrimethamine in a highly malarious area of Kenya: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine-pyrimethamine for the treatment of mild childhood anemia in western Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Scaling-up coverage with insecticide-treated nets against malaria in Africa: who should pay?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

The sick placenta-the role of malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Co-trimoxazole compared with sulfadoxine-pyrimethamine in the treatment of uncomplicated malaria in Kenyan children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Adverse events from drug therapy for human immunodeficiency virus disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Adverse reactions to cotrimoxazole in HIV-infected patients: predictive factors and subsequent HIV disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Editorial: antifolates in prevention of HIV-associated opportunistic infections and in intermittent preventive treatment of malaria in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Fatal Toxic Epidermal Necrolysis During Prophylaxis With Pyrimethamine and Sulfadoxine in a Human Immunodeficiency Virus—Infected Person

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Stevens-Johnson syndrome after mass prophylaxis with sulfadoxine for cholera in Mozambique

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Nevirapine-associated Stevens-Johnson syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

HIV drug nevirapine (Viramune): risk of severe hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Nelfinavir and nevirapine side effects during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: results of a randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: a double-blind, randomized trial. ANRS 005-ACTG 154 Group Members. Agence Nationale de Recherche sur le SIDA. AIDS Clinical Tr

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Causes and empirical treatment of fever in HIV-infected adult outpatients, Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

The potential for interactions between antimalarial and antiretroviral drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Pharmacokinetic interactions of antimalarial agents

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Dapsone therapy for malaria during pregnancy: maternal and fetal outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

No drug-drug interaction between nelfinavir or indinavir and mefloquine in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Effect of HIV-1 antiretroviral drugs on cytoadherence and phagocytic clearance of Plasmodium falciparum-parasitised erythrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Antiretrovirals as antimalarial agents.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Nutritional factors and infectious disease contribute to anemia among pregnant women with human immunodeficiency virus in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Anaemia prevention for reduction of mortality in mothers and children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

The WHO 'Roll Back Malaria Project': planning for adverse event monitoring in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breastfeeding and early child mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

A randomized trial of multivitamin supplements and HIV disease progression and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Vitamin supplementation of HIV-infected women improves postnatal child growth

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Cerebral malaria: optimising management

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Therapy of falciparum malaria in sub-saharan Africa: from molecule to policy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Malaria associated pre-eclampsia in Senegal

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Current issues in the treatment of uncomplicated malaria in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

Drugs for treating uncomplicated malaria in pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970383-8

7 January 2021

10.1016/S1473-3099(06)70383-8

Identifiers

DOI

1 reference

13 August 2017

1 reference